Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 04, 2007. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares in accordance with shareholder authority granted at the Annual General Meeting on May 23, 2007.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on share capital movements.
- Shares Repurchased: 1,950,000 ordinary shares.
- Repurchase Price: 1,329.56 pence per share.
- Treasury Shares Held: 422,819,158 shares (representing 7.55% of total voting rights).
- Shares in Issue: 5,601,501,255 shares (excluding Treasury shares).
Material Changes
The primary material change is the increase in the company's Treasury share holdings following the October 04, 2007 transaction. The total number of shares in issue remains 5,601,501,255, which serves as the denominator for calculating shareholder notification thresholds under the Financial Services Authority's Disclosure and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the total number of shares in issue (5,601,501,255) for calculating disclosure thresholds.
- Confirm the updated Treasury share count (422,819,158) and its percentage of voting rights (7.55%).
- Note that this filing does not contain financial performance data; refer to Form 20-F for comprehensive financial results.